Ascendis Pharma A/S

Ascendis Pharma A/S

Ascendis Pharma A/S

Overview
Date Founded

2006

Headquarters

Tuborg Boulevard 12,Hellerup, Capital Region 2900

Type of Company

Public

Employees (Worldwide)

251 - 500

Industries

Pharmaceuticals
Holding Companies
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.

Contact Data
Trying to get in touch with decision makers at Ascendis Pharma A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder, President & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Global Chief Commercial Officer

Chief Legal Officer & Senior Vice President

Senior Vice President, Head of Innovation & Research

Senior Vice President, Head of Oncology

Senior Vice President, Head-Clinical Development & Medical Affairs

Senior Vice President & Chief Administrative Officer

Vice President, Finance & Principal Accounting Officer

Senior Vice President, Product Supply & Quality

Paths to Ascendis Pharma A/S
Potential Connections via
Relationship Science
You
Ascendis Pharma A/S
Owners & Shareholders
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

APLP focuses exclusively on active, high value-added investment strategies where experienced investment professionals pursue superior results through a combination of original thinking and a disciplined investment approach based on a bottom-up process that covers a range of geographic areas and focuses on investments in growth and value stocks. The firm places particular emphasis on identifying and investing in well-managed companies with dominant or increasing market shares. They also closely monitor market valuation. Their autonomous investment teams oversee a range of investment strategies across diversified market capitalizations, regions and styles. All accounts managed by the firm regardless of investment strategy, invest primarily in common stocks and other equity securities. Their distribution strategy is focused on sophisticated investors around the globe that operate with institutional decision-making processes and longer-term investment horizons.

Details Hidden

BBA pursues a fundamentally-driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities.

Recent Transactions
Details Hidden

Ascendis Pharma A/S issued USD American Depositary Shares

Details Hidden

Ascendis Pharma A/S issued USD American Depositary Shares

Details Hidden

Ascendis Pharma A/S issued USD American Depositary Shares

Transaction Advisors
Legal Advisor

Advised onAscendis Pharma A/S issued USD American Depositary Shares

Underwriter

Advised onAscendis Pharma A/S issued USD American Depositary Shares

Underwriter

Advised onAscendis Pharma A/S issued USD American Depositary Shares

Underwriter

Advised onAscendis Pharma A/S issued USD American Depositary Shares

Legal Advisor

Advised onAscendis Pharma A/S issued USD American Depositary Shares

Legal Advisor

Advised onAscendis Pharma A/S issued USD American Depositary Shares

Advisors & Consultants
Publicist

Managing Director at ICR LLC

Consultant

Former Chief Medical Officer & Executive Vice President at Veloxis Pharmaceuticals A/S

Publicist

Founder at Spark BioComm LLC

Key Stats and Financials As of 2020
Market Capitalization
$8.38B
Total Enterprise Value
$7.67B
Earnings Per Share
$-9.44
Revenue
$7.93M
Net Profit
$-478M
EBITDA
$-366M
EBITDAMargin
-4,619.19%
Total Debt
$113M
Total Equity
$1.03B
Debt TEV
0.01x
TEVNet Income
-16.07x
Enterprise Value / Sales
968.29x
Investors
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Vivo Capital is an active manager which invests in companies located in the US. The firm participates in early stage capital transactions and focuses on sectors such as healthcare and life sciences.

Details Hidden

Rock Springs’ funds aims to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing in healthcare and healthcare-related industries, with a particular emphasis on those companies and/or products that Rock Springs believes serve critical unmet needs.

Suppliers
NOF Corp. Chemicals | Tokyo, Japan

NOF Corp. engages in the functional chemicals, life science, and pharmaceutical products businesses. It operates through the following business divisions: Oleo & specialty Chemicals, Functional Chemicals & Polymers, Explosives & Propulsion, Functional Foods, Life Science Products, DDS Development, Anti-Corrosion, and Others. The Oleo & specialty Chemicals division provides fats and glycerin, fatty acid derivatives, surfactants, petrochemical products and advanced polymers. The , Functional Chemicals & Polymers division produces polybutene, orgaic peroxides, petrochemicals, functional polymers, blocked carboxylic acid related products, isoparafin-baced odorless solvents and other products. The Explosives & Propulsion division supplies products to various areas related to daily lives such as automotive safety devices, marine equipment, thermal indicator materials, sterilizing materials, pharmaceutical materials, and crime prevention devices. The Functional Foods division engages in the processing of oils and fats for food contributes widely to the food industry by striving for the development of products in pursuit of deliciousness based on the technologies cultivated as a pioneer of processing oils and fats such as margarine, shortening, refined fat for confectionery use, depanning oil, filling and topping materials, powder oils and fats, and materials for cooking and frozen foods. The Life Science Products division provides biocompatible materials; products for eye care, skin care, oral care, and other care products; medical device products, diagnostic reagents, oxidative stress antibody products and fiber processing agents. The DDS Development division produces PEGylation and activated PEGs, phospholipid and liposomes, ultra-purity polysorbate 80, and cell membrane modifiers. The Anti-Corrosion division provides metal anti- corrosion treatments, dry galvanizing treatment, and sealers. The Others division engages in the logistics business, real estate sales, and insurance agency services. The company was founded on June 1, 1937 and is headquartered in Tokyo, Japan.

FUJIFILM Holdings Corp. Accounting & Financial Services | Tokyo, Japan

FUJIFILM Holdings, Inc. engages in the development, production, sales and service of imaging, information, and document solutions. It operates through the following segments: Imaging Solutions, Information Solutions, and Document Solutions. The Imaging Solutions segment handles color films, digital cameras, optical devices, color paper, services and equipment for photofinishing, instant photo systems, etc. The Information Solutions segment deals with the equipment and materials for medical systems, life sciences products, pharmaceuticals, graphic arts, flat panel display materials, recording media and electronic materials, etc. The Document Solutions segment provides office copy machines/MFPs, printers, production systems and services, office services, paper and consumables, etc. The company was founded on January 20, 1934 and is headquartered in Tokyo, Japan.

Dishman Carbogen Amcis Ltd. Other Business & Consulting Services | Ahmedabad, India

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. It operates through the Contract Research and Contract Manufacturing Services; and Others segment. The Others segment involves in the manufacture and marketing of bulk drugs, intermediates, vitamin D, quats and specialty chemicals, and outsourced and traded goods. The company was founded in 1983 and is headquartered in Ahmedabad, India.

Competitors
OPKO Health, Inc. Pharmaceuticals - Miami, FL

OPKO Health, Inc., is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Eli Lilly & Company Pharmaceuticals

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ascendis Pharma A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ascendis Pharma A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Ascendis Pharma A/S.